logo
Anti-Ransomware Day: Building Cyber Resilience To Address Evolving Threats

Anti-Ransomware Day: Building Cyber Resilience To Address Evolving Threats

Scoop12-05-2025

Press Release – Commvault
Today on Anti-Ransomware Day, Commvaults Darren Thomson said: Ransomware attacks continue to escalate year after year, and cybercriminals are no longer just chasing payouts theyre hunting for headlines.
One of the greatest challenges in combating ransomware is that, while new security tools and practices continue to emerge, threat actors are simultaneously advancing their tactics and becoming increasingly sophisticated. Ransomware and data theft extortion continue to be pervasive threats with business email compromise and fraud among the top self-reported cybercrimes for businesses and individuals in Australia in the 2024 financial year.
Today on Anti-Ransomware Day, Commvault's Darren Thomson said: 'Ransomware attacks continue to escalate year after year, and cybercriminals are no longer just chasing payouts – they're hunting for headlines. Recent attacks targeting high-profile organisations and critical supply chains show a clear shift in strategy: aiming for maximum disruption and publicity by targeting the 'big fish'.
Recent research found that on average, one cybercrime is reported every 6 minutes in Australia, with ransomware alone causing up to $3 billion in damages to the Australian economy every year. Yet, despite the rising threat, too many organisations remain underprepared. True cyber resilience means more than just defence, it also requires the ability to recover fast. This is where tools such as cleanroom environments come in. By restoring critical cloud services in a secure, isolated space and using automation to speed up recovery, companies can minimise downtime. While recovery takes 24 days on average, some organisations don't achieve business-as-usual for over 200, often due to poor preparation and a lack of understanding of their 'Minimum Viable Company' – the essential systems needed to stay operational.
But resilience isn't just a concern for businesses. Individuals must also take responsibility for their cybersecurity. The recent tech outages in Spain and Portugal bring a harsh reminder of how reliant we are on digital systems. Consumers should start by evaluating their own Minimum Viable Company: Could you manage without internet access? Do you have a backup plan if payment terminals go down?
'Taking practical steps like using secure password managers, avoiding password reuse, and steering clear of public Wi-Fi without a VPN are essential. On Anti-Ransomware Day, it's time for both businesses and consumers to assess their cyber resilience.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

AUKUS: A Very Antipodean Stupidity
AUKUS: A Very Antipodean Stupidity

Scoop

time24 minutes ago

  • Scoop

AUKUS: A Very Antipodean Stupidity

Call it abandonment, anxiety, or just latent stupidity. The messy goo of feelings and fuzzy notions behind Australia's most injudicious strategic decision is yielding its nasty harvest. Conceived by paranoid armchair strategists, flabby think tankers and profligate spenders happy to expend other people's money, the tripartite agreement between Australia, the United Kingdom and the United States is rapidly unravelling. Even during the Biden administration, under whose bumbling watch this agreement was hatched, there were doubts. The ogrish price tag (US$239 billion or A$368 billion) that would be billed to the Australian taxpayer; the absurd time schedules (delivery of nuclear-powered submarines by the 2030s and 2040s); the contingencies and qualifications (Congressional concerns about transferring Virginia Class (SSN-774) submarines to the Royal Australian Navy), all pointed to the fact that Canberra had fallen for a lemon, childishly refusing to taste its stinging bitterness. The central point of the tediously named Pillar One of the AUKUS agreement (there is no pillar, one or otherwise), which involves the transfer of US Virginia class boats to the RAN – was always its viability. While President Joe Biden was gradually losing his faculties in the White House, the Congressional Research Service was pertinently noting the obstacles that would face any transfer. The CRS report released on May 22, 2023 was the sort of thing that should have alarmed Australian defence planners, instead of turning them into paid up ostriches dreaming of consultancies. For one thing, it made it clear that Congress was always going to be the one to convince in the matter. 'One issue for Congress is whether to approve, reject, or modify DOD's AUKUS-related legislative package for the FY2024 NDAA [National Defense Authorization Act] sent to Congress on May 2, 2023'. That package included the authorisation for the transfer of 'up to two Virginia-class SSNs to the government of Australia in the form of sale, with the costs of the transfer to be covered by the government of Australia.' There were also weighty doubts about the 'net impact on collective allied deterrence and warfighting capabilities of transferring three to five Virginia-class boats to Australia while pursuing the construction of three to five replacement SSNs for the US Navy'. This is a point that has never gone away. To give, even to an ally, and a perceived advantage yet diminish, however small and fictional, the supposed power of the US submarine fleet, is never going to take place if the annual production of 1.2 Virginia boats remains as it is. Mississippi Senator Roger Wicker was always of the view that 'the AUKUS plan would transfer US Virginia-class submarines to a partner nation even before we have met our own Navy's requirements.' The fact that the Trump administration is now conducting a review of AUKUS can be seen as a mere formality – for those who think formalities smooth matters. The Australian Defence Minister Richard Marles certainly hopes so, calling it 'a completely natural step for an incoming government to take.' That Yankee stronghold of renown in Canberra, the Australian Strategic Policy Institute, apes the line with simian consistency: 'It's normal, after a change of government, for a new administration to review existing commitments in the light of new policy priorities: in this case, 'America First'.' But nothing about the Trump government is a formality, or any review's outcome a foregone conclusion. The presence of Undersecretary of Defense Policy Eldridge Colby should be disconcerting to the AUKUS band leaders and comparisons to Britain's own review of the pact by Sir Stephen Lovegrove should be seen as fantastically distant. 'AUKUS,' in Colby's assessment, 'is only going to lead to more submarines collectively in 10, 15, 20 years, which is way beyond the window of maximum danger, which is really this decade.' Putting to one side the warmongering stirring in the latter part of the statement, Colby is certainly not wrong about the time that will elapse before any delivery takes place. Down under, the strategists are scurrying and fretting, a sight that is proving enormously entertaining. But the political classes have only themselves to blame for this pigsty of a conundrum. As former Australian Prime Minister Malcolm Turnbull notes with snappy precision, the AUKUS agreement is perfectly positioned for the US to not follow through. It can still stick to the letter of the agreement without having to ever transfer a single submarine to Australia, all the time raking in Australian largesse. 'This is because it has always been part of the deal, and part of the US legislation, that the transfer of submarines to Australia is highly conditional.' The legislation in question notes that the President will submit to the relevant congressional committees and leadership a certification no later than 270 days prior to the transfer of vessels that the move 'will not degrade the United States underseas capabilities'; is consistent with the country's foreign policy and national security interests and furthers the AUKUS partnership. That furtherance, however, involves the US ensuring 'sufficient submarine production and maintenance investments' that will meet undersea capabilities; Australia supplying 'appropriate funds and support for the additional capacity required to meet the requirements' under the provisions; and Canberra's 'capability to host and fully operate the vessels authorized to be transferred.' The latest development in this overpriced show shows it up as a series of fictions: for Australia, the boyish hankering for nuclear powered submarines in the first place; for the United States, the fact that it needs more nuclear armed boats in order to look more ridiculous in having an arsenal it can never use. It was the military industrial complex in full song, nourished by expensive games, dubious scenarios and drab excuses for war. With Donald Trump in the White House, the Make America Great Again philosophy mushes the terminology of sweet friends and mortal foes, turning it into the mortar of self-interest. Washington's interests come first, and Australia's own idiotically misplaced interests are barely visible in the White House situation room. Then again, never ask Australian strategic thinkers about their interests, ever the hostage of governing fears and treasured prejudices.

Mill sale awaits Commerce Commission approval
Mill sale awaits Commerce Commission approval

Otago Daily Times

time11 hours ago

  • Otago Daily Times

Mill sale awaits Commerce Commission approval

The sale of a farmer-owned flour mill in South Canterbury's Washdyke must get Commerce Commission clearance to go ahead. The commission has received an application from George Weston Foods, trading as Mauri New Zealand, to buy the wheat milling and storage assets, including land, used by Farmers Mill. A purchase price was undisclosed with the sale subject to conditions including regulatory approval from the commission. The mill was opened at Washdyke in 2013 as New Zealand's only independent grower-owned and operated flour producer. Farmers Mill supplies bulk and bagged flour to industrial food manufacturers, bakeries, and some retailers. The mill is owned by Grainstor, South Island's largest grain storage facility. Directors for both companies are listed as Ashley Biggs, Raymond Bowan, Antony Howey and Murray Turley. A Commerce Commission spokeswoman said in a statement the commission could only give clearance to a proposed merger if it was satisfied it was unlikely to have the effect of substantially lessening competition in a market. Mauri operates flour mills in Auckland, Wellington and Christchurch, supplying flour in bulk to large users of flour such as industrial food manufacturers and bagged flour to wholesalers, bakeries and supermarkets. Mauri flour is also used by George Weston Foods' bakery division to produce breads and bakery goods under brands including Tip Top bread and Big Ben pies. Australian-based George Weston Foods is owned by Associated British Foods Plc, a company listed on the London Stock Exchange. Both Mauri and Farmers Mill also supply broll, which is a by-product of the wheat milling process and most commonly used as an input for animal feed. Farmers Mill bought its wheat milling plant from a company in Italy in 2012 for about $12 million. When the mill was launched the following year with former prime minister John Key cutting the ribbon, Mr Turley, as chairman, said South Canterbury arable farmers had teamed up to mill their own grain to gain more control of their grain production and create a homegrown product. "We have harnessed our own resources to secure the industry's future investing more than $10m to get Farmers Mill up and running," he said. Initially 12 local farmers were involved in the ground-up building of the mill. The commission expects to make a decision by early August.

St Vincent's Hospital Melbourne Signs Agreement With NZ MedTech Veriphi To Boost Medication Safety For Cancer Patients
St Vincent's Hospital Melbourne Signs Agreement With NZ MedTech Veriphi To Boost Medication Safety For Cancer Patients

Scoop

time20 hours ago

  • Scoop

St Vincent's Hospital Melbourne Signs Agreement With NZ MedTech Veriphi To Boost Medication Safety For Cancer Patients

Press Release – Veriphi The agreement marks the first commercial hospital contract for Veriphi, which has spent more than a decade developing an innovative analyser that uses laser spectrometry, AI and cloud computing to verify the identity and concentration of IV drugs in real … St Vincent's Hospital Melbourne has signed a 12-month supply agreement with New Zealand MedTech company Veriphi, to deploy its breakthrough intravenous medication verification technology in the hospital's sterile oncology compounding pharmacy. The agreement marks the first commercial hospital contract for Veriphi, which has spent more than a decade developing an innovative analyser that uses laser spectrometry, AI and cloud computing to verify the identity and concentration of IV drugs in real time. The goal: reduce preventable harm from medication errors and improve dosing accuracy for vulnerable cancer patients. St Vincent's Hospital Melbourne, a tertiary public healthcare provider with more than 880 beds and over 5,000 staff, is part of St Vincent's Health Australia – the country's largest not for-profit health and aged care provider. 'St Vincent's Hospital Melbourne is excited to be working with technology company Veriphi to improve medication safety in our sterile oncology compounding pharmacy,' said Andrew Cording, Chief Pharmacist from St Vincent's. 'The safety of our patients, including medication safety, is a top priority for St Vincent's, so we are proud to be working with world-leading technology.' The agreement reflects a shared commitment to innovation and safety in cancer care, with Veriphi's system designed to support pharmacists and clinical staff in verifying complex, high-risk medications. 'We are delighted to be working with St Vincent's Hospital Melbourne,' said Greg Shanahan, Managing Director of Veriphi. 'Our values regarding the protection of patient safety from medication error align perfectly with St Vincent's. We are proud to collaborate with an organisation whose culture and focus on patient outcomes are supported by Veriphi's breakthrough technology.' Medication errors remain one of the most serious – and preventable – threats to patient safety worldwide. Intravenous drugs, particularly those used in oncology, require precise handling and verification to avoid harm. Veriphi's analyser brings a new layer of safety, enabling hospitals to verify each dose at the point of compounding before administration to patients. The St Vincent's partnership marks a major milestone for Veriphi's commercial rollout, with further expansion plans underway across Australia, New Zealand, and the United States. Veriphi is currently raising funds to expand its impact around the globe. New Zealand and Australian residents can invest at

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store